Stock · SHL.DE · Healthcare
Germany · Large Cap · Revenue 12 mo. €23.2B
Price as of 11/06/2026
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Original text from the data provider
Summary
48.6 of 100
Mean of the six area values. Each area value is the mean of the stock's ranks among the companies in its sector. 50 is the middle of the sector, not a share of companies beaten.
Analysis
What the price requires
If free cash flow stays at €2.3B (2025), it supports €25.2B. The remaining €24.2B of the market value assume it grows 9.5% a year for 10 years and not at all afterwards.
Required FCF growth per year
9.5%
no growth afterwards
Price to operating cash flow 16.5×, below its usual range.
Middle half of 20 quarters: 18.5× to 29.8×, median 24.9×.
Measures only against its own past, not against what the company is worth. Price as of 11/06/2026.
with respect to the priced-in expectation
with respect to the priced-in expectation
Since the last quarter
Q1 → Q2 2026
7 more unchanged: Revenue, 12 mo., Gross margin, EBIT margin, FCF margin, Net debt, Shares outstanding, Return on equity
Derivation
Each area value is the average of its metrics' ranks within the sector (0 to 100, 50 is the middle). For metrics where lower is better, the rank is mirrored. The overall value is the average of the area values.
Price as of 11/06/2026.
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Return on equity | 11.88% | 11.52% | Rank 51 |
| Return on capital (Greenblatt) | 55.70% | 32.55% | Rank 74 |
| EBIT margin | 14.70% | 18.31% | Rank 39 |
| FCF margin | 9.69% | 14.12% | Rank 35 |
| Gross margin | 38.63% | 60.99% | Rank 23 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Revenue growth, 1 year | 4.53% | 8.04% | Rank 30 |
| Earnings growth, 3 years per year | 1.80% | 5.44% | Rank 40 |
| Earnings growth, 5 years per year | 6.29% | 7.00% | Rank 46 |
| Sustainable growth (ROE × retained earnings) | 3.50% | 3.66% | Rank 45 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Earnings yield | 4.27% | 2.90% | Rank 72 |
| FCF yield | 4.59% | 3.63% | Rank 64 |
| EV/saleslower is better | 2.66 | 4.03 | Rank 64 |
| EV/EBITlower is better | 18.13 | 21.73 | Rank 66 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Share price, 1 year | −8.77% | 8.66% | Rank 32 |
| Share price, 6 months | 33.24% | 24.27% | Rank 72 |
| Share price, 3 months | 18.17% | 15.42% | Rank 60 |
| Distance from 52-week high | −5.08% | −7.35% | Rank 59 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Accruals (Sloan)lower is better | −0.07% | 0.30% | Rank 54 |
| Change in share countlower is better | 0.12% | 0.00% | Rank 31 |
| Dividend streak in years | 6 | 10 | Rank 54 |
| Price reaction to results, market-adjusted | −1.11% | 0.05% | Rank 34 |
| Metric | Stock | Sector median | Position in sector |
|---|---|---|---|
| Equity ratio | 40.66% | 48.40% | Rank 33 |
| Net debt/EBITDAlower is better | 2.81 | 1.11 | Rank 17 |
| Debt to equitylower is better | 0.83 | 0.48 | Rank 27 |
| Volatility, 1 yearlower is better | 25.01% | 31.42% | Rank 88 |
Ten years in figures
| Year | Revenue, €B | EBIT margin | FCF | Shares | Net debt |
|---|---|---|---|---|---|
| 2016 | 13.5 | 15.6% | €1.2B | 1.00B | €9.4B |
| 2017 | 13.7 | 16.2% | €1.3B | 1.00B | €10.8B |
| 2018 | 13.4 | 15.2% | €910.0M | 1.00B | €4.2B |
| 2019 | 14.5 | 15.9% | €919.0M | 1.00B | −€779.0M |
| 2020 | 14.5 | 14.1% | €1.4B | 1.00B | €4.8B |
| 2021 | 18.0 | 15.4% | €2.3B | 1.10B | €13.0B |
| 2022 | 21.7 | 14.1% | €1.7B | 1.13B | −€704.0M |
| 2023 | 21.7 | 11.3% | €1.3B | 1.12B | −€1.0B |
| 2024 | 22.4 | 14.8% | €1.8B | 1.12B | €13.5B |
| 2025 | 23.4 | 14.7% | €2.3B | 1.12B | €12.9B |
3 of 7 StockScorer Score rules met · How the score is built
Siemens Healthineers AG mainly meets criteria in the Valuation category. Result from 18 strategies checked.
Siemens Healthineers AG is rated here with the StockScorer Score strategy, the flagship rule set. It compares return and cash-flow metrics with the median of the company's own sector and checks growth and price trend.
3 of 7 rules met
5 of 11 points
Detail data
Excerpt from 18 strategies checked. The full evaluation is visible after a free sign-up.
With a free account, you can see the match across all strategies checked in one complete overview.
Selected fundamental metrics for Siemens Healthineers AG.
| Metric | Stock | Sector |
|---|---|---|
| P/E ratio | 23.4 | 30.0 |
| P/B ratio | 2.8 | 4.8 |
| Return on equity (ROE) | 11.9% | 11.5% |
| Equity ratio | 40.7% | 48.4% |
| Debt-to-equity (D/E) | 0.83 | 0.48 |
| Dividend yield | 2.2% | 1.3% |
How comparable stocks in the same sector score in the StockScorer model.
| Symbol | Company | Rating |
|---|---|---|
| SHL.DE | Siemens Healthineers AGthis page | |
| EW | Edwards Lifesciences Corp | Low1.8 |
| BSX | Boston Scientific Corp | High9.1 |
| GEHC | GE HealthCare Technologies Inc. | Low4.5 |
| 300760.SZ | Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | locked |
| PHIA.AS | Koninklijke Philips NV | locked |
Signed up in 30 seconds, free.
Learn more about the metrics in the metrics glossary or all rated stocks in the stock overview.
How StockScorer rates every stock is explained on the methodology page.